Recommendations in cIPMACT-NOW Update 12 Should Identify Grade 2 IDH-Mutant Astrocytoma Patients with Truly Low Risk Disease by Pathology

Daniel J Brat, Martin J van den Bent; Recommendations in cIPMACT-NOW Update 12 Should Identify Grade 2 IDH-Mutant Astrocytoma Patients with Truly Low Risk

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2026-09-04
DOI
https://doi.org/10.1093/neuonc/noag216
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recommendations in cIPMACT-NOW Update 12 Should Identify Grade 2 IDH-Mutant Astrocytoma Patients with Truly Low Risk Disease by Pathology

Martin J van den Bent, Daniel J Brat
Neuro-Oncology
Glioma Diagnosis and Treatment
article

Recommendations in cIPMACT-NOW Update 12 Should Identify Grade 2 IDH-Mutant Astrocytoma Patients with Truly Low Risk Disease by Pathology

Martin J van den Bent, Daniel J Brat
article en

Abstract

Daniel J Brat, Martin J van den Bent; Recommendations in cIPMACT-NOW Update 12 Should Identify Grade 2 IDH-Mutant Astrocytoma Patients with Truly Low Risk

Neuro-Oncology
Northwestern University (US), Erasmus MC Cancer Institute (NL)
Openalex Percentile: Top 11%
Glioma Diagnosis and Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.